It’s Okay to Not Be Okay

Everything You Need to Know About JPA Health’s Public Health Practice

A Letter to the Optimists

Full disclosure: I am an optimist. I’m always looking for that silver lining and the bright side of a situation. Throughout the emotional turmoil and frustrations of the last year, I have forced [...]

A New Congress and A New President: What to Expect

What happens when you take four policy and public affairs professionals from two different parties and ask them what they think the health policy agenda looks like following the 2020 elections? [...]

Maybe Doctors will Save Us

As the United States is trying to heal from a divisive election and a surging pandemic, O’Dwyer’s republished our recent article, “Maybe Doctors Will Save Us” from its magazine. The timing could [...]

Decision 2020: Start Public Affairs Planning Today

The concurrent effects of the novel coronavirus and sweeping demands for racial equity are, arguably, creating the greatest social disruption America has witnessed in the last 50 years. While the [...]

Leveraging Communication to Address a Crisis – How “Flatten the Curve” Spread

Communicating public health messages during a pandemic necessitates the ability to reach everyone quickly. This role has traditionally belonged to government leaders, but with so much [...]

Do your words match your intent? How to avoid stigma in health messaging

“Good words are worth much, and cost little.” – George Herbert As communications professionals, we all know how much words matter. Raise your hand if you have recently spent way too long noodling [...]

Tips for Staying Productive While Working From Home

It’s 5:15 a.m. and my alarm begins its obnoxious yell—TIME TO GET UP! After hitting snooze (miraculously only once), I begrudgingly roll out of bed. After changing into clothes that are [...]

Regulating Drug Development Is a Winning Strategy for All

The FDA Office of New Drugs held a public meeting earlier this month to invite discussions and policy suggestions that promote effective drug development programs. Considering the unprecedented [...]

page 1 of 3